Haleon Belgium
The computed 12-month bankruptcy probability of Haleon Belgium is 0.3% (very low). The company has been active since 1968 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 58 yrs |
| Board | 4 |
| Locations | 1 |
| Publications | 25 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 21-08-2025 | 2025-00447507 |
| 31-12-2023 | volledig | 03-10-2024 | 2024-00504113 |
| 31-12-2022 | volledig | 04-07-2023 | 2023-00226763 |
| 31-12-2021 | volledig | 30-05-2022 | 2022-20050556 |
| 31-12-2020 | volledig | 15-06-2021 | 2021-20700151 |
| 31-12-2019 | volledig | 13-07-2020 | 2020-29500518 |
| 31-12-2018 | volledig | 04-09-2019 | 2019-63900101 |
| 31-12-2017 | volledig | 10-09-2018 | 2018-62600354 |
| 31-12-2016 | volledig | 30-11-2017 | 2017-70800462 |
| 31-12-2015 | volledig | 27-07-2016 | 2016-37800480 |
-
Marco DorigoDirectorState Gazette act 24003060 (05-01-2024)Current05-01-2024 → present
-
Sabena SolomonManaging directorState Gazette act 22061047 (19-05-2022)Current19-05-2022 → present
-
Gilles MartinDirectorState Gazette act 24003060 (05-01-2024)Current01-10-2020 → present
3 events
- 05-01-2024 Appointed· Director
- 19-05-2022 Appointed· Director
- 01-10-2020 Appointed· Director
-
Jorg Van DammeDirectorState Gazette act 24003060 (05-01-2024)Current26-02-2019 → present
3 events
- 05-01-2024 Appointed· Director
- 19-05-2022 Appointed· Director
- 26-02-2019 Appointed· Director
Historic, not recently confirmed (3)
-
Sofi NAERTDirectorState Gazette act 16111564 (08-08-2016)Not recently confirmedlast confirmed in an act from 2016
-
Anne DelzongleDirectorState Gazette act 07081013 (07-06-2007)Not recently confirmedlast confirmed in an act from 2007
-
Andrew WatersDirectorState Gazette act 05110644 (01-08-2005)Not recently confirmedlast confirmed in an act from 2005
Permanent representatives (1)
-
Ellemarie BexVaste vertegenwoordiger commissarisState Gazette act 23164895 (22-12-2023)Permanent representative22-12-2023 → present
Former directors (15)
-
Dries PattynManaging directorState Gazette act 20114643 (01-10-2020)Former01-10-2020 → 06-06-2023
3 events
- 06-06-2023 Resigned· Gedelegeerd bestuurder en bestuurder
- 19-05-2022 Resigned· Managing director
- 01-10-2020 Appointed· Managing director
-
Hans MoonsDirectorState Gazette act 19011556 (23-01-2019)Former23-01-2019 → 01-10-2020
2 events
- 01-10-2020 Resigned· Director
- 23-01-2019 Appointed· Director
-
James BarhamDirectorState Gazette act 18186083 (31-12-2018)Former31-12-2018 → 01-10-2020
3 events
- 01-10-2020 Resigned· Managing director
- 31-12-2018 Appointed· Director
- 31-12-2018 Appointed· Managing director
-
Libor BALLEKDirectorState Gazette act 16111564 (08-08-2016)Former25-07-2016 → 26-02-2019
3 events
- 26-02-2019 Resigned· Director
- 08-08-2016 Appointed· Director
- 25-07-2016 Appointed· Director
-
Celesta BloemenDirectorState Gazette act 17160702 (16-11-2017)Former16-11-2017 → 23-01-2019
2 events
- 23-01-2019 Resigned· Director
- 16-11-2017 Appointed· Director
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| KPMG Bedrijfsrevisoren BV/SRLCurrent Statutory auditor |
- | 22-12-2023 → present |
Show 8 earlier auditors
| Deloitte Bedrijfsrevisoren BV Statutory auditor |
- | - → 22-12-2023 |
| Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL Commissaire succeeded by KPMG Bedrijfsrevisoren BV/SRL in 2023 |
- | 16-11-2021 → 22-12-2023 |
| Deloitte Réviseurs d'Entreprises SCRL Commissaire succeeded by Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL in 2021 |
- | 29-01-2019 → 16-11-2021 |
| Didier DELANOYE Commissaire succeeded by Deloitte Réviseurs d'Entreprises SCRL in 2019 |
- | 08-08-2016 → 29-01-2019 |
| Emmanuelle Attout Commissaire succeeded by SCCRL PwC Reviseurs d'Entreprises in 2016 |
- | 04-08-2010 → 08-08-2016 |
| PricewaterhouseCoopers Reviseurs d'Entreprises SCRL Commissaire succeeded by Emmanuelle Attout in 2010 |
- | 07-06-2007 → 04-08-2010 |
| PricewaterhouseCoopers Réviseurs d'Entreprises SCRL Commissaire |
- | - → 29-01-2019 |
| SCCRL PwC Reviseurs d'Entreprises Commissaire succeeded by Deloitte Réviseurs d'Entreprises SCRL in 2019 |
- | 08-08-2016 → 29-01-2019 |
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Public limited company(014) |
| Incorporation | 01-01-1968 |
| Status | Active |
| Postal code | 1930 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23094D0081/00F003 | Flanders | 8,103 m² | 1 · 1,497 m² | 38.6 m · 12 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 33 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
05-01-2024 3 directors appointed
- Marco Dorigo, Bestuurder
- Gilles Martin, Bestuurder
- Jorg Van Damme, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marco Dorigo",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gilles Martin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jorg Van Damme",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "Haleon Belgium"
}
}22-12-2023 2 directors appointed, 1 resigning
- KPMG Bedrijfsrevisoren BV/SRL, Commissaris
- Ellemarie Bex, Vaste vertegenwoordiger commissaris
- Deloitte Bedrijfsrevisoren BV, Commissaris
Technical details
{
"events": [
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Deloitte Bedrijfsrevisoren BV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "KPMG Bedrijfsrevisoren BV/SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger commissaris",
"person": {
"rrn": null,
"name": "Ellemarie Bex",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "Haleon Belgium"
}
}06-06-2023 Dries Pattyn resigns as gedelegeerd bestuurder en bestuurder
- Dries Pattyn, Gedelegeerd bestuurder en bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "gedelegeerd bestuurder en bestuurder",
"person": {
"rrn": null,
"name": "Dries Pattyn",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "Haleon Belgium"
}
}02-03-2023 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Tim Carnewal",
"firm_city": null,
"firm_name": "BERQUIN NOTAIRES",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-03-02",
"filing_date": null,
"act_kind_objet": "TRANSFERT DU SIEGE VERS LA REGION FLAMANDE"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-02-17",
"unanimous": null
},
"conversion": {
"effective_date": null,
"jurisdiction_to": "BE",
"legal_form_after": "Soci\u00E9t\u00E9 anonyme",
"jurisdiction_from": "BE",
"legal_form_before": "Soci\u00E9t\u00E9 anonyme"
},
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0404.195.238",
"name": "GlaxoSmithKline Consumer Healthcare",
"role": "demerged",
"address": "1300 Wavre, Avenue Pascal 2-4-6",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:103"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": "Le si\u00E8ge social de la soci\u00E9t\u00E9 est transf\u00E9r\u00E9 de Wavre \u00E0 Zaventem, en R\u00E9gion flamande. L\u0027activit\u00E9 de la soci\u00E9t\u00E9 est maintenue, mais la langue de fonction passera au n\u00E9erlandais.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim Carnewal",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de GlaxoSmithKline Consumer Healthcare a d\u00E9cid\u00E9 de transf\u00E9rer le si\u00E8ge social de Wavre \u00E0 Zaventem, en R\u00E9gion flamande. \u00C0 compter de ce transfert, la langue de la soci\u00E9t\u00E9 deviendra le n\u00E9erlandais.",
"co_filed_documents": [
"une exp\u00E9dition du proc\u00E8s-verbal"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "zetel"
}24-02-2023 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "Haleon Belgium",
"old": "GlaxoSmithKline Consumer Healthcare",
"changed": true
},
"seat_change": {
"changed": true
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}24-02-2023 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "Haleon Belgium",
"old": "GlaxoSmithKline Consumer Healthcare",
"changed": true
},
"seat_change": {
"changed": true
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}19-05-2022 3 directors appointed, 1 resigning
- Gilles Martin, Bestuurder
- Sabena Solomon, Gedelegeerd bestuurder
- Jorg Van Damme, Bestuurder
- Dries Pattyn, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Gilles Martin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Dries Pattyn",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Sabena Solomon",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jorg Van Damme",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
}
}16-11-2021 Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL appointed as commissaire
- Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises SRL, Commissaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Deloitte Bedrijfsrevisoren/R\u00E9viseurs d\u0027Entreprises SRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "Glaxosmithkline Consumer Healthcare"
}
}01-10-2020 2 directors appointed, 2 resigning
- Gilles Martin, Bestuurder
- Dries Pattyn, Gedelegeerd bestuurder
- Hans Moons, Bestuurder
- James Barham, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Hans Moons",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Gilles Martin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "James Barham",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Dries Pattyn",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
}
}26-02-2019 1 director appointed, 1 resigning
- Jorg Van Damme, Bestuurder
- Libor Ballek, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Libor Ballek",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jorg Van Damme",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}29-01-2019 1 director appointed, 1 resigning
- Deloitte Réviseurs d'Entreprises SCRL, Commissaire
- PricewaterhouseCoopers Réviseurs d'Entreprises SCRL, Commissaire
Technical details
{
"events": [
{
"kind": "director_out",
"role": "commissaire",
"person": {
"rrn": null,
"name": "PricewaterhouseCoopers R\u00E9viseurs d\u0027Entreprises SCRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises SCRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}23-01-2019 1 director appointed, 1 resigning
- Hans Moons, Bestuurder
- Celesta Bloemen, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Celesta Bloemen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Hans Moons",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}31-12-2018 2 directors appointed, 1 resigning
- James Barham, Bestuurder
- James Barham, Gedelegeerd bestuurder
- Olivier Bronkhorst, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Olivier Bronkhorst",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "James Barham",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "James Barham",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}13-04-2018 2 directors appointed, 2 resigning
- Olivier Bronkhorst, Bestuurder
- Olivier Bronkhorst, Gedelegeerd bestuurder
- Bas Vorsteveld, Bestuurder
- Bas Vorsteveld, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Bas Vorsteveld",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Bas Vorsteveld",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Olivier Bronkhorst",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Olivier Bronkhorst",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}16-11-2017 1 director appointed, 1 resigning
- Celesta Bloemen, Bestuurder
- Sofie Naert, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Sofie Naert",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Celesta Bloemen",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}12-06-2017 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
}
}17-10-2016 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "completed",
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2016-10-17",
"filing_date": "2016-07-11",
"act_kind_objet": "FUSION PAR ABSORPTION DE NOVARTIS CONSUMER HEALTH -"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2016-09-26",
"unanimous": null
},
"conversion": {
"effective_date": null,
"jurisdiction_to": "BE",
"legal_form_after": "soci\u00E9t\u00E9 anonyme",
"jurisdiction_from": "BE",
"legal_form_before": "soci\u00E9t\u00E9 anonyme"
},
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0404.195.238",
"name": "GlaxoSmithKline Consumer Healthcare",
"role": "acquiring",
"address": "Site Apollo, avenue Pascal 2-4-6, 1300 Wavre",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0403.097.356",
"name": "NOVARTIS CONSUMER HEALTH",
"role": "absorbed",
"address": "1800 Vilvoorde, Medialaan 40",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": 695.46,
"legal_articles": [
"12:7",
"12:50",
"12:75",
"12:103",
"693"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2015-12-31",
"exchange_ratio_text": "695,46 nouvelles actions au nom de la Soci\u00E9t\u00E9 Absorbante contre remise de 1 action de la Soci\u00E9t\u00E9 Absorb\u00E9e",
"new_shares_issued_n": 208637,
"real_estate_included": false,
"patrimony_description": "La totalit\u00E9 du patrimoine de la Soci\u00E9t\u00E9 Absorb\u00E9e, sans exception ni r\u00E9serve, est transf\u00E9r\u00E9e \u00E0 titre universel \u00E0 la Soci\u00E9t\u00E9 Absorbante. L\u0027op\u00E9ration inclut le transfert universel du patrimoine, y compris les actifs, passifs et droits.",
"equity_transferred_eur": null,
"accounting_effective_date": "2016-01-01"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare",
"legal_form": "soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Eubelius",
"person_name": null,
"org_rep_person_name": "Rebecca Danby, Ewout Epping, Jorg van Damme"
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de GlaxoSmithKline Consumer Healthcare, r\u00E9unie le 26 septembre 2016, a approuv\u00E9 la fusion par absorption de NOVARTIS CONSUMER HEALTH, dont le patrimoine a \u00E9t\u00E9 transf\u00E9r\u00E9 universellement \u00E0 la soci\u00E9t\u00E9 absorbante. Cette fusion a \u00E9t\u00E9 effectu\u00E9e conform\u00E9ment aux dispositions de l\u0027article 693 du Code des soci\u00E9t\u00E9s, avec attribution de 208.637 nouvelles actions \u00E0 l\u0027actionnaire unique de la soci\u00E9t\u00E9 absorb\u00E9e, au taux d\u0027\u00E9change de 695,46 nouvelles actions par action existante. Le capital social de GlaxoSmithKline Consumer Healthcare a \u00E9t\u00E9 augment\u00E9 \u00E0 5.798.470,50 EUR.",
"co_filed_documents": [
"une exp\u00E9dition du proc\u00E8s-verbal",
"une procuration",
"le texte coordonn\u00E9 des statuts"
],
"detected_real_type": "fusion_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}08-08-2016 4 directors appointed, 2 resigning
- Libor BALLEK, Bestuurder
- Sofi NAERT, Bestuurder
- SCCRL PwC Reviseurs d'Entreprises, Commissaire
- Didier DELANOYE, Commissaire
- Simon HODGE, Bestuurder
- Carlton LAWSON, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Simon HODGE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Carlton LAWSON",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Libor BALLEK",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Sofi NAERT",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "SCCRL PwC Reviseurs d\u0027Entreprises",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Didier DELANOYE",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}25-07-2016 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": "Joris De Wolf",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2016-07-25",
"filing_date": "2016-06-23",
"act_kind_objet": ""
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2016-06-23",
"unanimous": true
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0404.195.238",
"name": "GlaxoSmithKline Consumer Healthcare SA",
"role": "acquiring",
"address": "Avenue Pascal 2-4-6, 1300 Wavre (Belgique)",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0403.097.356",
"name": "Novartis Consumer Health NV",
"role": "absorbed",
"address": "Medialaan 40, 1800 Vilvoorde (Belgique)",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": 695.46,
"legal_articles": [
"693",
"74",
"648"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2015-12-31",
"exchange_ratio_text": "695,46 Nouvelles Actions pour chaque action",
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "Tous les actifs et passifs de Novartis Consumer Health NV sont transf\u00E9r\u00E9s \u00E0 GlaxoSmithKline Consumer Healthcare SA par un transfert d\u0027universalit\u00E9. Le patrimoine transf\u00E9r\u00E9 inclut les activit\u00E9s pharmaceutiques, chimiques et alimentaires, ainsi que les brevets, marques et licences associ\u00E9s.",
"equity_transferred_eur": null,
"accounting_effective_date": "2016-01-01"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Joris De Wolf",
"org_rep_person_name": null
},
"summary_narrative": "Le projet de fusion par absorption pr\u00E9voit la dissolution sans liquidation de Novartis Consumer Health NV, dont tous les actifs et passifs seront transf\u00E9r\u00E9s \u00E0 GlaxoSmithKline Consumer Healthcare SA. En \u00E9change, les actionnaires de NVS Belgique recevront 695,46 nouvelles actions nominatives sans valeur nominale. La fusion prendra effet le 1er octobre 2016, avec une r\u00E9troactivit\u00E9 comptable et fiscale \u00E0 partir du 1er janvier 2016. Les assembl\u00E9es g\u00E9n\u00E9rales extraordinairement des actionnaires seront tenues vers le 23 septembre 2016.",
"co_filed_documents": [
"Rapport du commissaire de NVS Belgique",
"Rapport du commissaire de GSK Belgique",
"Comptes annuels des trois derniers exercices de GSK Belgique et NVS Belgique",
"Rapports du conseil d\u0027administration et du commissaire pour les trois derniers exercices"
],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}04-02-2016 Bas Vorsteveld appointed as director
- Bas Vorsteveld, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Bas Vorsteveld",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}17-06-2015 3 directors appointed, 3 resigning
- Carlton LAWSON, Bestuurder
- Simon HODGE, Bestuurder
- Bas VORSTEVELD, Bestuurder
- Anton VAN DE PUTTE, Bestuurder
- Adrian BAUER, Bestuurder
- René FLASCHKER, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Anton VAN DE PUTTE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Adrian BAUER",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Ren\u00E9 FLASCHKER",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Carlton LAWSON",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Simon HODGE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Bas VORSTEVELD",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}04-08-2010 Emmanuelle Attout appointed as commissaire
- Emmanuelle Attout, Commissaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Emmanuelle Attout",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}09-02-2009 Act object · Incorporation · General meeting · Board meeting
- Act object: constitution et nomination des premiers administrateurs et de l'administrateur-délégué · Belgian Association of Consumer Healthcare Industry
- Publication: 2009-02-09 · Belgian Association of Consumer Healthcare Industry
- Filing: 2009-01-29 · Belgian Association of Consumer Healthcare Industry
- Incorporation: 2008-12-12 · Belgian Association of Consumer Healthcare Industry
- General meeting: 2008-12-12 · Belgian Association of Consumer Healthcare Industry
- Board meeting: 2008-12-12 · Belgian Association of Consumer Healthcare Industry
- Purpose: la représentation et la défense des intérêts moraux et matériels de l'industrie Consumer Healthcare étant, au sens large du terme, l'ensemble des entreprises actives en Belgique dans le domaine des médicaments qui peuvent être délivrés sans ordonnance comme des produits qui ne tombent pas sous l'appellation de médicaments. · Belgian Association of Consumer Healthcare Industry
- First fiscal year: 2008-12-12 to 2009-12-31 · Belgian Association of Consumer Healthcare Industry
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Hernando Acosta-Stoefs
- Officer appointment: role: administrateur, start_date: 2008-12-12 · An De Mulder
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Marc Gryseels
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Guido Van Hoeck
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Marc Verlinden
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Hans De Seranno
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Gerrit Coremans
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Luc Huys
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Laurent Bendavid
- Officer appointment: role: administrateur, start_date: 2008-12-12 · Tim Southerst
- Officer appointment: role: administrateur-délégué, start_date: 2008-12-12 · Marc Gryseels
- Officer appointment: role: président, start_date: 2008-12-12 · Marc Verlinden
- Officer appointment: role: vice-président, start_date: 2008-12-12 · Guido Van Hoeck
- Officer appointment: role: trésorier, start_date: 2008-12-12 · Gerrit Coremans
- Mandate term: au moins jusqu'à l'Assemblée Générale qui doit approuver les comptes annuels se rapportant à l'exercice comptable 2011, après quoi le système de rotation de l'article 11 entre en vigueur · Belgian Association of Consumer Healthcare Industry
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Objet de l\u0027acte: constitution et nomination des premiers administrateurs et de l\u0027administrateur-d\u00E9l\u00E9gu\u00E9",
"value": "constitution et nomination des premiers administrateurs et de l\u0027administrateur-d\u00E9l\u00E9gu\u00E9",
"object": null,
"subject": "e1"
},
{
"date": "2009-02-09",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 09/02/2009 - Annexes du Moniteur belge",
"value": "2009-02-09",
"object": null,
"subject": "e1"
},
{
"date": "2009-01-29",
"type": "filing",
"quote": "29-01-2009",
"value": "2009-01-29",
"object": null,
"subject": "e1"
},
{
"date": "2008-12-12",
"type": "incorporation",
"quote": "Le 12 d\u00E9cembre 2008, les soussign\u00E9s, fondateurs de l\u0027Association, ... ont d\u00E9cid\u00E9 de constituer une association sans but lucratif de droit belge",
"value": "2008-12-12",
"object": null,
"subject": "e1"
},
{
"date": "2008-12-12",
"type": "general_meeting",
"quote": "Apr\u00E8s avoir \u00E9tabli les statuts de l\u0027Association, les fondateurs ont tenu une Assembl\u00E9e G\u00E9n\u00E9rale Sp\u00E9ciale et ont adopt\u00E9 les r\u00E9solutions suivantes \u00E0 l\u0027unanimit\u00E9:",
"value": "2008-12-12",
"object": null,
"subject": "e1"
},
{
"date": "2008-12-12",
"type": "board_meeting",
"quote": "Apr\u00E8s l\u0027Assembl\u00E9e G\u00E9n\u00E9rale Sp\u00E9ciale, un Conseil d\u0027Administration s\u0027est \u00E9galement tenu en date du 12/12/2008.",
"value": "2008-12-12",
"object": null,
"subject": "e1"
},
{
"type": "purpose",
"quote": "L\u0027Association a pour objet social la repr\u00E9sentation et la d\u00E9fense des int\u00E9r\u00EAts moraux et mat\u00E9riels de l\u0027industrie Consumer Healthcare \u00E9tant, au sens large du terme, l\u0027ensemble des entreprises actives en Belgique dans le domaine des m\u00E9dicaments qui peuvent \u00EAtre d\u00E9livr\u00E9s sans ordonnance comme des produits qui ne tombent pas sous l\u0027appellation de m\u00E9dicaments.",
"value": "la repr\u00E9sentation et la d\u00E9fense des int\u00E9r\u00EAts moraux et mat\u00E9riels de l\u0027industrie Consumer Healthcare \u00E9tant, au sens large du terme, l\u0027ensemble des entreprises actives en Belgique dans le domaine des m\u00E9dicaments qui peuvent \u00EAtre d\u00E9livr\u00E9s sans ordonnance comme des produits qui ne tombent pas sous l\u0027appellation de m\u00E9dicaments.",
"object": null,
"subject": "e1"
},
{
"date": "2008-12-12",
"type": "first_fiscal_year",
"quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale Sp\u00E9ciale a d\u00E9cid\u00E9 que le premier exercice social d\u00E9butera ce jour et s\u0027ach\u00E8vera le 31 d\u00E9cembre 2009.",
"value": "2008-12-12 to 2009-12-31",
"object": null,
"subject": "e1"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "L\u0027 Assembl\u00E9e G\u00E9n\u00E9rale Sp\u00E9ciale a d\u00E9cid\u00E9 de nommer comme administrateurs les personnes suivantes: *Monsieur Hernando Acosta-Stoefs, General Manager, domicili\u00E9 \u00E0 1790 Affligem, Zwarteberg 59, ayant comme num\u00E9ro de registre national 66.01.24-333.49:",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e11"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "\u2022Madame An De Mulder, Business Unit Director, domicili\u00E9e \u00E0 9660 Brakel, Boekelstraat 17, ayant comme num\u00E9ro de registre nalional 66.05.20-406.27;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e12"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "Monsieur Marc Gryseels, domicili\u00E9 \u00E0 Lasne, 1380, Rue Collart, 3A, ayant comme num\u00E9ro de registre national 61.10.24-037.12;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e13"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "\u2022Monsieur Guido Van Hoeck, Country Manager, domicili\u00E9 \u00E0 Kapelle-op-den-Bos, 1880, Overzetstraat 28. ayant comme num\u00E9ro de registre national 55.05.18-157.08:",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e14"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "\u2022Monsieur Marc Verlinden, administrateur-d\u00E9l\u00E9gu\u00E9, domicili\u00E9 \u00E0 Beersel, 1653, Beukenlaan, 60, ayant comme num\u00E9ro de registre national 69.09.03-391.61;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e15"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "\u2022Monsieur Hans De Seranno, Sales Manager Pharmacy Benelux, domicili\u00E9 \u00E0 Destelbergen 9070, Gaverstraat 31, ayant comme num\u00E9ro de registre national 63.04.01-033.27:",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e16"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "\u2022Monsieur Gemit Coremans, OTC Director, domicili\u00E9 \u00E0 Lennik 1750, Waterhoflaan 45, ayant comme num\u00E9ro de registre national 57.05.29-395.64;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e17"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "Monsieur Luc Huys, General Manager, repr\u00E9sent\u00E9 par Monsieur Leo Vervoort, domicili\u00E9 \u00E0 Kapelien 2950. Blauwhof Hoevensebaan 206/2, ayant comme num\u00E9ro de registre national 60.05.06-013.35;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e18"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "Monsieur Laurent Bendavid, Marketing Manager, domicili\u00E9 \u00E0 _ ayant comme num\u00E9ro de registre national 67.02.18-133.69;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e19"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "\u2022Monsieur Tim Southerst, Director, domicili\u00E9 \u00E0_ ayant comme num\u00E9ro de registre national GBR passport n\u00B0705059517;",
"value": {
"role": "administrateur",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e20"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "1.d\u00E9sign\u00E9 la personne suivante en qualit\u00E9 d\u0027administrateur-d\u00E9l\u00E9gu\u00E9 de l\u0027Association: -Monsieur Marc Gryseels, pr\u00E9cil\u00E9, qui a accept\u00E9 son mandat.",
"value": {
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e13"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "2.d\u00E9sign\u00E9 la personne suivante en qualit\u00E9 de pr\u00E9sident de l\u0027Association: -Monsieur Marc Verlinden, pr\u00E9cit\u00E9, qui a accept\u00E9 son mandat.",
"value": {
"role": "pr\u00E9sident",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e15"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "3.d\u00E9sign\u00E9 la personne suivante en qualit\u00E9 de vice-pr\u00E9sident de l\u0027Association: -Monsieur Guido Van Hoeck, pr\u00E9cit\u00E9, qui a accept\u00E9 son mandat.",
"value": {
"role": "vice-pr\u00E9sident",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e14"
},
{
"date": "2008-12-12",
"type": "officer_appointment",
"quote": "4. d\u00E9sign\u00E9 la personne suivante en quasit\u00E9 de tr\u00E9sorier de l\u0027Association: -Monsieur Gerrit Coremans, pr\u00E9cit\u00E9, qui a accept\u00E9 son mandat.",
"value": {
"role": "tr\u00E9sorier",
"start_date": "2008-12-12"
},
"object": "e1",
"subject": "e17"
},
{
"type": "mandate_term",
"quote": "En guise de mesure provisoire, les premiers membres du Conseil d\u0027Administration qui sont nomm\u00E9s actuellement rempliront leur mandat au moins jusqu\u0027\u00E0 l\u0027Assembl\u00E9e G\u00E9n\u00E9rale qui doit approuver les comptes annuels se rapportant \u00E0 l\u0027exercice comptable 2011. A partir de ce moment, le syst\u00E8me de rotation, tel que mis en place \u00E0 l\u0027article 11 des pr\u00E9sents statuts, entrera en vigueur.",
"value": "au moins jusqu\u0027\u00E0 l\u0027Assembl\u00E9e G\u00E9n\u00E9rale qui doit approuver les comptes annuels se rapportant \u00E0 l\u0027exercice comptable 2011, apr\u00E8s quoi le syst\u00E8me de rotation de l\u0027article 11 entre en vigueur",
"object": null,
"subject": "e1"
}
],
"act_meta": {
"outcome": "corrected",
"postfix": [
"kbo \u002709.465.691\u0027 invalid -\u003E register 0809.465.691"
],
"model_id": 53,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 34932,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0809.465.691",
"kind": "company",
"name": "Belgian Association of Consumer Healthcare Industry",
"attrs": {
"seat": "Rue Collart 3A, 1380 Lasne",
"kbo_raw": "09.465.691",
"kbo_source": "register",
"legal_form": "ASBL",
"short_name": "BACHI"
}
},
{
"id": "e2",
"kbo": "0400.948.213",
"kind": "company",
"name": "BAYER",
"attrs": {
"seat": "1050 Bruxelles, avenue Louise 143",
"legal_form": "SA"
}
},
{
"id": "e3",
"kbo": "0404.195.238",
"kind": "company",
"name": "GLAXOSMITHKLINE CONSUMER HEALTHCARE",
"attrs": {
"seat": "1332 Genval, rue du Tilleul 13",
"legal_form": "SA"
}
},
{
"id": "e4",
"kbo": "0452.453.827",
"kind": "company",
"name": "MCNEIL",
"attrs": {
"seat": "2600 Berchem, Roderveldlaan 1",
"legal_form": "SCA"
}
},
{
"id": "e5",
"kbo": "0401.988.388",
"kind": "company",
"name": "MELISANA",
"attrs": {
"seat": "1140 Evere, Kareelovenlaan 1",
"legal_form": "SA"
}
},
{
"id": "e6",
"kbo": "0462.252.213",
"kind": "company",
"name": "NEOCARE",
"attrs": {
"seat": "1020 Bruxelles, Esplanade du Heysel 22",
"legal_form": "SA"
}
},
{
"id": "e7",
"kbo": "0403.097.356",
"kind": "company",
"name": "NOVARTIS CONSUMER HEALTH",
"attrs": {
"seat": "1800 Vilvoorde, Medialaan 30, bte 5",
"legal_form": "SA"
}
},
{
"id": "e8",
"kbo": "0414.882.559",
"kind": "company",
"name": "NYCOMED",
"attrs": {
"seat": "1080 Bruxelles, Chauss\u00E9e de Gand 615",
"legal_form": "SA"
}
},
{
"id": "e9",
"kbo": "0403.086.468",
"kind": "company",
"name": "QUALIPHAR",
"attrs": {
"seat": "2880 Bornem, Rijksweg 9",
"legal_form": "SA"
}
},
{
"id": "e10",
"kbo": "0860.530.550",
"kind": "company",
"name": "METHAPHARMA",
"attrs": {
"seat": "8400 Oostende, Wetenschapspark 1",
"legal_form": "SA"
}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Hernando Acosta-Stoefs",
"attrs": {
"rrn": "66.01.24-333.49",
"address": "1790 Affligem, Zwarteberg 59"
}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "An De Mulder",
"attrs": {
"rrn": "66.05.20-406.27",
"address": "9660 Brakel, Boekelstraat 17"
}
},
{
"id": "e13",
"kbo": null,
"kind": "person",
"name": "Marc Gryseels",
"attrs": {
"rrn": "61.10.24-037.12",
"address": "Lasne, 1380, Rue Collart, 3A"
}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Guido Van Hoeck",
"attrs": {
"rrn": "55.05.18-157.08",
"address": "Kapelle-op-den-Bos, 1880, Overzetstraat 28"
}
},
{
"id": "e15",
"kbo": null,
"kind": "person",
"name": "Marc Verlinden",
"attrs": {
"rrn": "69.09.03-391.61",
"address": "Beersel, 1653, Beukenlaan, 60"
}
},
{
"id": "e16",
"kbo": null,
"kind": "person",
"name": "Hans De Seranno",
"attrs": {
"rrn": "63.04.01-033.27",
"address": "Destelbergen 9070, Gaverstraat 31"
}
},
{
"id": "e17",
"kbo": null,
"kind": "person",
"name": "Gerrit Coremans",
"attrs": {
"rrn": "57.05.29-395.64",
"address": "Lennik 1750, Waterhoflaan 45"
}
},
{
"id": "e18",
"kbo": null,
"kind": "person",
"name": "Luc Huys",
"attrs": {
"rrn": "60.05.06-013.35",
"address": "Kapelien 2950, Blauwhof Hoevensebaan 206/2"
}
},
{
"id": "e19",
"kbo": null,
"kind": "person",
"name": "Laurent Bendavid",
"attrs": {
"rrn": "67.02.18-133.69",
"address": null
}
},
{
"id": "e20",
"kbo": null,
"kind": "person",
"name": "Tim Southerst",
"attrs": {
"rrn": "GBR passport n\u00B0705059517",
"address": null
}
}
]
}07-06-2007 2 directors appointed, 1 resigning
- Anne Delzongle, Bestuurder
- PricewaterhouseCoopers Reviseurs d'Entreprises SCRL, Commissaire
- Georges Dassonville, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Georges Dassonville",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Anne Delzongle",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "PricewaterhouseCoopers Reviseurs d\u0027Entreprises SCRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GLAXOSMITHKLINE CONSUMER HEALTHCARE"
}
}01-08-2005 1 director appointed, 1 resigning
- Andrew Waters, Bestuurder
- Schipper, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Schipper",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Andrew Waters",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0404.195.238",
"name_full": "GlaxoSmithKline Consumer Healthcare"
}
}| Legal nameFR | Haleon Belgium |
| Legal nameNL | Haleon Belgium |